Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
None listed
Sponsors
OMRON HEALTHCARE Co., Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients living in India. 2. Patients diagnosed with hypertension and on stable hypertension medication > 3 months. 3. Patients who are thoroughly informed about the study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with Pregnancy-Induced Hypertension. 2. Shift workers or patients working for odd hours (working between 5 pm and 9 am). 3. Patients with arm circumference of 42 cm. 4. Patients deemed unfit to participate in the study due to a health condition.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Distribution of patients based on BP control status by the difference in the clinic and home BP thresholds into 4 categories: white-coat hypertension, masked hypertension, well-controlled hypertension, and sustainable uncontrolled hypertension. The BP control status will also be investigated by regions and expressed with graphical bars.Timepoint: At the end of data collection completion. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes / Clinical â?¢ To find out the correlation of demographic, anthropometric, socioeconomic, medical condition, medication use, and lifestyle factors to BP control status and HR, including data collected from unique demographics in India. â?¢ To examine BP and HR variability for visit-to-visit CBP, day-by-day HBP, morning HBP, and evening HBP. â?¢ Comparison between the digitally recorded BP measurement and manually recorded. Secondary outcomes / Behavioural â?¢ To investigate the knowledge, attitude and practice (KAP) of HBPM by hypertensive patients in India. â?¢ Determine the association between KAP, physiciansâ?? instructions of HBPM and prescription usage to BP control among hypertensive patients. â?¢ To investigate the change in patientâ??s KAP regarding HBP from visit1 patient Home BP survey and visit 2 feedback survey.ã?? Timepoint: At the end of data collection completion. | — |
Countries
India
Contacts
Public ContactNarsingh Verma
King Georges Medical University
Outcome results
None listed